‘Fair inclusion score’ ranks pharma companies on their clinical trial diversity

A team of researchers have devised a tool to measure the fair inclusion of various demographic groups in clinical trials. The fair inclusion score method was applied to pivotal oncology trials conducted between 2012–2017, to rank 25 biopharmaceutical companies on their clinical trial diversity and transparency. The fair inclusion score criteria aimed to find out whether these trials truly represent the US patient population for the studied conditions and grades pharmaceutical companies on their fair representation of women, older adults and racially and ethnically minoritized patients. "The lack of diversity in clinical research is a social justice and a public...